Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
NCT ID: NCT06272422
Last Updated: 2024-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
165 participants
OBSERVATIONAL
2024-10-31
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To this end, two types of examination are carried out, both of which are used in current practice:
* Pre-operatively: EOS radiography
* Post-operatively: EOS radiograph and CT scan
Inclusion (m-3; m-1) :
* Patient information at pre-operative visit
* Non-opposition of patient, family member or legal guardian, if applicable
* Questionnaires and clinical examination (standard management)
* EOS during anesthetic consultation
Follow-up visit (m+3):
\- Post-operative follow-up consultation EOS and CT scan (1 week prior to visit) + questionnaire and clinical examination
Follow-up visit (m+12):
\- Post-operative check-up, questionnaire and clinical examination
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CT-based 3D Planning, Computer Navigation and Subsequent Migration Analysis in Total Hip Arthroplasty
NCT05159206
Cup Position in THA With Standard Instruments
NCT03189303
Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis
NCT01668160
Total Hip Arthroplasty: Fluoroscopy vs Freehand
NCT05653687
Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis
NCT06258369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
total hip arthroplasty (THA)
Standard THA, the head and neck of the femur are cut.
hip arthroplasty
resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.
Total hip prosthesis with femoral neck preservation
A total hip replacement is performed, but the neck of the femur is preserved and the head of the femur is cut off.
hip arthroplasty
resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.
Hip resurfacing
the head and neck of the femur are preserved.
hip arthroplasty
resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hip arthroplasty
resurfacing procedures (HRP), THA and Minihip-type neck-preserving total hip arthroplasty.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Planned surgery: total hip arthroplasty, Minihip or RSA
* Absence of osteoarthritis or osteoarthritis ≤ stage 1 (Tönnis classification) of contralateral hip (Radiographic analysis)
* Patient having given his/her non-opposition to participate in the study
* Patient with social insurance
* Patient willing to comply with all study procedures and duration
Exclusion Criteria
* Anomalies or anatomical changes of the hip, pelvis or lumbar spine (history of fracture, protrusion, scoliosis, history of orthopedic surgery, dysplasia, torsion disorder)
* Established genetic disease affecting the musculoskeletal system
* Severe or morbid obesity
* Neuromuscular pathologies affecting the limb girdles
* Severe osteoporosis
* Bone location of primary or metastatic cancer (spine, pelvis or femur) - Inequality of lower limb length \> 2 cm.
* Minors
* Protected adults
* Pregnant or breast-feeding women
* Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security coverage, refusal to participate.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00358-37
Identifier Type: OTHER
Identifier Source: secondary_id
2022/0472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.